Company / Cash per Share
Orchestra BioMed Holdings, Inc. Cash per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.91
FY2025
5-year range
$0.62 / $1.51
FY2023-FY2025
Trend
+46.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1.51 to $0.91 over the past 2 years.
Based on SEC 10-K filings.
0.91 in FY2025.
Declined from $1.51 to $0.91 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 46.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.91 | +46.0% |
| FY2024 | $0.62 | -58.9% |
| FY2023 | $1.51 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026